ONWRF (Onward Medical NV) Other Stockholders Equity: $7.96 Mil (As of Dec. 2025)


ONWRF Onward Medical NV ONWRF
37 GF Score
Price $2.94
GF Value $176.09
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Onward Medical NV Other Stockholders Equity?

Onward Medical NV ONWRF 37 Other Stockholders Equity is $7.96 Mil as of Dec. 2025. GuruFocus rates ONWRF with a GF Score™ of 37/100 and a GF Value™ of $176.09 (Possible Value Trap). The stock has 4 warning signs investors should review.

Onward Medical NV's Other Stockholders Equity for the quarter that ended in Dec. 2025 was $7.96 Mil.

Onward Medical NV's quarterly Other Stockholders Equity increased from Dec. 2024 ($7.09 Mil) to Jun. 2025 ($7.65 Mil) and increased from Jun. 2025 ($7.65 Mil) to Dec. 2025 ($7.96 Mil).

Onward Medical NV's annual Other Stockholders Equity increased from Dec. 2023 ($4.89 Mil) to Dec. 2024 ($7.09 Mil) and increased from Dec. 2024 ($7.09 Mil) to Dec. 2025 ($7.96 Mil).

Onward Medical NV Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Onward Medical NV's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Onward Medical NV Other Stockholders Equity Chart

Onward Medical NV Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only -0.24 2.20 4.89 7.09 7.96

Onward Medical NV Semi-Annual Data
Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.89 4.97 7.09 7.65 7.96
ONWRF
37GF Score
Onward Medical NV ONWRF
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Onward Medical NV Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $7.96 Mil mean?
Onward Medical NV (ONWRF) has a Other Stockholders Equity of $7.96 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Onward Medical NV and its competitors.
Is Onward Medical NV's Other Stockholders Equity too high?
Onward Medical NV's current Other Stockholders Equity is $7.96 Mil. Overall, Onward Medical NV has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Onward Medical NV's Other Stockholders Equity compare to VRTX and REGN?
Onward Medical NV's Other Stockholders Equity of $7.96 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Onward Medical NV and its competitors. Onward Medical NV's current Other Stockholders Equity is $7.96 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onward Medical NV stock overvalued right now?
Based on GuruFocus' analysis, Onward Medical NV (ONWRF) is currently considered Possible Value Trap. The stock's GF Value™ is $176.09, compared to a current price of $2.94 — trading 98.3% below its estimated fair value. The current Other Stockholders Equity is $7.96 Mil. Onward Medical NV's overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Onward Medical NV (ONWRF), the current Other Stockholders Equity is $7.96 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Onward Medical NV (ONWRF) Overvalued in 2026?

Based on GuruFocus' analysis, Onward Medical NV stock appears to be undervalued. The current stock price of $2.94 is trading 98.3% below its estimated GF Value™ of $176.09. GuruFocus considers Onward Medical NV to be Possible Value Trap.

Key valuation signals for ONWRF:

  • Other Stockholders Equity: $7.96 Mil
  • GF Value™: $176.09 vs. price of $2.94 (98.3% below fair value)
  • GF Score™: 37/100 with 4 warning signs

No single metric tells the full story. See the ONWRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Onward Medical NV Business Description

Other Exchanges 63E:GermanyONWD:Belgium
Address Schimmelt 2, Eindhoven, NH, NLD, NL-5656
Onward Medical NV is developing and commercializing therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company's technology platforms are based on ONWARD ARC Therapy (ARC Therapy), targeted, programmed electrical stimulation of the spinal cord designed to restore movement, independence, and health in people with SCI.
37GF Score

Get the complete analysis for ONWRF

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.94
Price
$176.09
GF Value